Search details
1.
Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys.
Cell
; 155(3): 531-9, 2013 Oct 24.
Article
in English
| MEDLINE | ID: mdl-24243013
2.
Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection.
PLoS Pathog
; 13(7): e1006510, 2017 Jul.
Article
in English
| MEDLINE | ID: mdl-28759651
3.
Correction: Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection.
PLoS Pathog
; 13(9): e1006620, 2017 Sep.
Article
in English
| MEDLINE | ID: mdl-28910384
4.
Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 Acquisition.
J Immunol
; 197(7): 2726-37, 2016 10 01.
Article
in English
| MEDLINE | ID: mdl-27591322
5.
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys.
Nature
; 482(7383): 89-93, 2012 Jan 04.
Article
in English
| MEDLINE | ID: mdl-22217938
6.
Immune-correlates analysis of an HIV-1 vaccine efficacy trial.
N Engl J Med
; 366(14): 1275-86, 2012 Apr 05.
Article
in English
| MEDLINE | ID: mdl-22475592
7.
Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trial.
J Virol
; 87(3): 1708-19, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-23175374
8.
Frequent and Durable Anti-HIV Envelope VIV2 IgG Responses Induced by HIV-1 DNA Priming and HIV-MVA Boosting in Healthy Tanzanian Volunteers.
Vaccines (Basel)
; 8(4)2020 Nov 13.
Article
in English
| MEDLINE | ID: mdl-33202967
9.
New Subtype B Containing HIV-1 Circulating Recombinant of sub-Saharan Africa Origin in Nigerian Men Who Have Sex With Men.
J Acquir Immune Defic Syndr
; 81(5): 578-584, 2019 08 15.
Article
in English
| MEDLINE | ID: mdl-31107298
10.
HIV-1 genetic diversity and demographic characteristics in Bulgaria.
PLoS One
; 14(5): e0217063, 2019.
Article
in English
| MEDLINE | ID: mdl-31136611
11.
Unravelling the complicated evolutionary and dissemination history of HIV-1M subtype A lineages.
Virus Evol
; 4(1): vey003, 2018 Jan.
Article
in English
| MEDLINE | ID: mdl-29484203
12.
Molecular epidemiology of a primarily MSM acute HIV-1 cohort in Bangkok, Thailand and connections within networks of transmission in Asia.
J Int AIDS Soc
; 21(11): e25204, 2018 11.
Article
in English
| MEDLINE | ID: mdl-30601598
13.
HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania.
AIDS Res Hum Retroviruses
; 33(4): 373-381, 2017 04.
Article
in English
| MEDLINE | ID: mdl-27841669
14.
Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition.
Nat Med
; 22(7): 762-70, 2016 07.
Article
in English
| MEDLINE | ID: mdl-27239761
15.
The Number and Complexity of Pure and Recombinant HIV-1 Strains Observed within Incident Infections during the HIV and Malaria Cohort Study Conducted in Kericho, Kenya, from 2003 to 2006.
PLoS One
; 10(8): e0135124, 2015.
Article
in English
| MEDLINE | ID: mdl-26287814
16.
Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trial.
PLoS One
; 8(1): e53629, 2013.
Article
in English
| MEDLINE | ID: mdl-23349725
17.
The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120.
AIDS Res Hum Retroviruses
; 28(11): 1444-57, 2012 Nov.
Article
in English
| MEDLINE | ID: mdl-23035746
18.
Corrigendum: Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition.
Nat Med
; 22(10): 1192, 2016 10 06.
Article
in English
| MEDLINE | ID: mdl-27711066
Results
1 -
18
de 18
1
Next >
>>